Astra's pact with the Medical Research Council (MRC), the first of its kind, will offer 22 clinical compounds to academics for free.
They will be compounds known to have an active biological function, but where it is unclear whether they are targeting the right disease.
via telegraph.co.uk
No comments:
Post a Comment